CoV Spike Porcine

Mouse Anti Porcine Coronavirus Spike Monoclonal
Shipped with Ice Packs
In Stock

Description

Introduction to CoV Spike Porcine

The term "CoV Spike Porcine" refers to the spike (S) glycoprotein of coronaviruses that infect swine, including porcine deltacoronavirus (PDCoV), porcine epidemic diarrhea virus (PEDV), porcine respiratory coronavirus (PRCV), and swine acute diarrhea syndrome coronavirus (SADS-CoV). The spike protein is a critical viral entry machinery that mediates receptor binding and membrane fusion, determining host tropism and pathogenesis . Recent studies highlight its zoonotic potential, structural diversity, and role in interspecies transmission .

Domain Organization

  • S1 Subunit: Responsible for receptor binding. Contains N-terminal (NTD) and C-terminal (CTD) domains .

  • S2 Subunit: Mediates membrane fusion via hydrophobic fusion peptides .

Cryo-EM and Crystallographic Insights

  • PDCoV Spike: Resolved at 3.3-Å resolution, revealing a prefusion trimer with distinct NTD and CTD orientations .

  • SADS-CoV Spike: Shares structural homology with betacoronaviruses in the NTD but diverges in the CTD .

  • PDCoV-Human APN Complex: Crystal structures show conserved binding interfaces between PDCoV S1-CTD and human/porcine APN .

Primary Receptors

  • Aminopeptidase N (APN): Utilized by PDCoV, PEDV, and PRCV for cell entry. APN knockout reduces infection by >90% in vitro .

  • d-Glucuronyl C5-Epimerase (GLCE): Identified as a PDCoV co-receptor that enhances S1 binding to APN .

Synergistic Binding

  • GLCE promotes PDCoV attachment by bridging S1 and APN, increasing viral internalization efficiency .

  • PDCoV S1-CTD binds APN residues 288–294 in pigs and humans, enabling cross-species transmission .

Key Mutations in PDCoV Spike

  • NTD Insertion (Position 52): Enhances B-cell epitope affinity and viral loads in Taiwanese strains .

  • S1-CTD Mutations: Increase APN-binding affinity, correlating with higher virulence .

Table 2: Impact of Spike Protein Mutations on Viral Fitness

Mutation SiteVirusEffect on PathogenicityViral Load Increase (log10)
NTD (A52ins)PDCoVEnhanced membrane fusion and intestinal tropism 5.0
S1-CTD (Q345L)PDCoVStrengthened APN binding; zoonotic potential N/A
S1-NTD (R238K)PEDVAltered sialic acid binding; reduced cell entry N/A

Cross-Species Transmission Potential

  • Human APN Compatibility: PDCoV S1-CTD binds human APN with comparable efficiency to porcine APN .

  • Broad Host Range: PDCoV experimentally infects chickens, cows, and human cell lines .

  • Zoonotic Evidence: PDCoV RNA detected in humans with febrile illness, suggesting spillover risk .

Neutralizing Antibodies

  • Anti-S1 Antibodies: Target PDCoV S1-NTD and S1-CTD, disrupting APN binding and inducing conformational changes .

  • Anti-GLCE Antibodies: Block PDCoV attachment by masking the GLCE-S1 interaction site .

Small-Molecule Inhibitors

  • ZINC12899676: Suppresses PEDV replication by inhibiting NTPase activity (IC50 = 4.7 μM) .

Table 3: Therapeutic Strategies Targeting Spike Proteins

TargetCompound/ApproachMechanismEfficacy (In Vitro)
PDCoV S1-CTDMonoclonal antibodyBlocks APN binding; neutralizes PDCoV90% infection reduction
PEDV NTPaseZINC12899676Inhibits viral replication5-log TCID50 reduction
PRCV SpikeTrimeric nanoparticleInduces cross-reactive antibodiesUnder evaluation

Product Specs

Introduction
The SARS Coronavirus, an enveloped virus, possesses three key outer structural proteins: membrane (M), envelope (E), and spike (S) proteins. The spike (S) glycoprotein facilitates viral entry into susceptible target cells by interacting with a cellular receptor and mediating membrane fusion. This crucial role in the virus infection cycle makes the S-protein a primary target for neutralizing antibodies. Studies have confirmed that SARS (severe acute respiratory syndrome) is linked to a human coronavirus. These viruses are recognized as major contributors to upper respiratory tract illnesses in humans, including the common cold. Classified as positive-stranded RNA viruses, coronaviruses are notable for having the largest known viral RNA genomes, ranging from 27-31 kb. The initial stage of coronavirus infection involves the binding of the viral spike protein, a 139-kDa protein, to specific receptors on host cells. This spike protein serves as the main surface antigen of the coronavirus. Both the glycosylated spike protein and the nucleocapsid protein can be detected in infected cell culture supernatants using antisera from SARS patients.
Formulation
Provided at a concentration of 1 mg/ml in a solution of 1X PBS at pH 7.2 with 0.01% NaN3.
Applications
This porcine Coronavirus Spike monoclonal antibody is suitable for use in Western Blot (WB) and Enzyme-Linked Immunosorbent Assay (ELISA) applications.
Stability
For short-term storage, keep at 4°C for up to 2 weeks. For long-term storage, maintain at -20°C.
Type
Mouse antibody Monoclonal.
Immunogen

The antibody was developed using purified porcine coronavirus. (eptopoe not mapped)

Isotype

IgG2a

Q&A

What are the main porcine coronaviruses and how do their spike proteins differ structurally?

The main porcine coronaviruses include alphacoronaviruses (Porcine epidemic diarrhea virus/PEDV and Transmissible gastroenteritis virus/TGEV), deltacoronaviruses (Porcine deltacoronavirus/PDCoV), and other emerging viruses like Swine acute diarrhea syndrome coronavirus (SADS-CoV).

Structurally, TGEV, PEDV, and PDCoV spike proteins contain two functional domains: spike_rec_binding and corona_S2, while SADS-CoV contains only the corona_S2 domain . Alphacoronaviruses like PEDV have a unique N-terminal domain 0 (D0) not found in other coronavirus genera .

Korean PEDV isolates show significant structural variations, with S genes nine nucleotides longer than reference strains due to a 15 bp insertion and 6 bp deletion in the N-terminal region of the S1 domain . Sequence comparisons reveal that Korean isolates share 93.6-99.6% identity with each other but only 92.2-93.7% identity with reference strains .

What receptor interactions govern porcine coronavirus host specificity?

PDCoV demonstrates remarkable cross-species potential by binding to aminopeptidase N (APN) from different host species, including humans . Crystal structures show that PDCoV receptor binding domain (RBD) binds to common regions on human APN (hAPN) and porcine APN (pAPN), which differ from binding sites used by alphacoronaviruses like HCoV-229E and porcine respiratory coronavirus (PRCoV) .

Structure-guided mutagenesis has identified conserved residues on hAPN and pAPN essential for PDCoV binding and infection . This broad receptor usage explains PDCoV's ability to experimentally infect multiple species including chickens, calves, and mice, as well as its reported infection of humans .

What post-translational modifications influence porcine coronavirus spike protein function?

Porcine coronavirus spike proteins undergo extensive post-translational modifications that influence their structure and function:

Phosphorylation sites:

  • TGEV: 139 sites

  • PEDV: 143 sites

  • SADS-CoV: 109 sites

  • PDCoV: 124 sites

N-linked glycosylation sites:

  • TGEV: 24 sites

  • PEDV: 22 sites

  • SADS-CoV: 20 sites

  • PDCoV: 18 sites

Glycosylation particularly impacts protein folding, stability, and immune recognition. In PEDV, specific N-glycans modulate the conformation of the D0 domain . Mass spectrometry and cryo-EM analyses have mapped the spatial distribution of these glycans, demonstrating that a key N-glycan plays a functional role in modulating D0 conformation .

How do dynamics of spike protein domains influence porcine coronavirus function?

Cryo-electron tomography (cryo-ET) and cryo-electron microscopy (cryo-EM) studies have revealed asynchronous motions of the Domain 0 (D0) of spike proteins on intact PEDV viral particles . These motions likely represent different functional states related to receptor binding and membrane fusion processes.

The D0 domain, unique to alphacoronaviruses, can adopt different architectures corresponding to distinct functional states . Domain motions are directly associated with receptor binding capability, with certain conformations potentially favoring attachment to cellular receptors.

These structural dynamics highlight the sophisticated mechanisms that coronaviruses employ to infect cells and suggest potential targets for intervention strategies that could lock the spike protein in non-functional conformations.

What molecular determinants in spike proteins drive virulence differences between PEDV strains?

Recombinant virus experiments have definitively shown that spike proteins alone can determine PEDV virulence independent of other viral components . Using a common DR13 backbone with different spike proteins:

  • rDR13-S^DR13 (DR13 spike): No diarrhea, no virus shedding, indicating no virulence

  • rDR13-S^UU (UU spike): 91.6% of piglets developed mild to severe diarrhea but recovered by day 5

  • rDR13-S^GDU (GDU spike): All piglets developed severe diarrhea, with 66.7% mortality

Virulent spike variants led to higher viral shedding (approximately 8.3-8.4 log₁₀ genome copies/mL in fecal samples) and produced more severe clinical signs, including lower rectal temperatures . These findings demonstrate that specific regions of the spike protein are critical determinants of coronavirus pathogenicity.

Protease sensitivity may play a key role, as trypsin enhanced infection for some recombinant viruses but not others . Domain-swapping experiments represent a promising approach for further pinpointing specific regions responsible for virulence differences .

What mechanisms enable PDCoV's cross-species transmission capability?

PDCoV's ability to cross species barriers is explained by several structural and functional adaptations:

  • Broad receptor recognition: PDCoV binds to common regions on aminopeptidase N (APN) from different species, including humans

  • Conserved receptor binding interface: Structure-guided mutagenesis identified conserved residues on APN across species that are essential for PDCoV binding

  • Evolutionary adaptation: Phylogenetic analysis suggests PDCoV evolved from an avian deltacoronavirus ancestor, being closely related to sparrow CoV HKU17, bulbul CoV HKU11, and munia CoV HKU13

  • Experimental evidence: PDCoV successfully infects chickens, calves, and mice in laboratory settings

  • Human infection: PDCoV has been isolated from plasma samples of children with acute febrile illness, confirming its zoonotic potential

These findings reveal how deltacoronaviruses can overcome species barriers and highlight the importance of surveillance for emerging coronaviruses with pandemic potential.

What structural biology approaches are most effective for studying porcine coronavirus spike proteins?

Multiple complementary approaches have proven effective for studying spike protein structures:

X-ray crystallography:

  • Successfully used to determine crystal structures of PDCoV RBD bound to human and porcine APN

  • Provides atomic-level details of binding interfaces

Cryo-electron microscopy (cryo-EM):

  • Revealed recombinant PEDV S protein structure derived from porcine cell lines

  • Identified domain motions associated with receptor binding

Cryo-electron tomography (cryo-ET):

  • Demonstrated asynchronous S protein D0 motions on intact viral particles

  • Provides insights into functional states in near-native environments

Integrated approaches:

  • Combining mass spectrometry with cryo-EM to map glycosylation patterns

  • Integration of structural data with functional assays

These methods together provide a comprehensive understanding of coronavirus spike protein structure, dynamics, and function that informs therapeutic development.

How can recombinant virus systems be designed to study spike protein domain functions?

Recombinant virus systems offer powerful approaches to isolate spike protein effects:

  • Backbone-and-swap strategy:

    • Using a common viral backbone (e.g., attenuated strain) with different spike proteins

    • Example: rDR13-S^DR13, rDR13-S^UU, and rDR13-S^GDU recombinant PEDV viruses created by inserting different S genes into the same DR13 backbone

  • Domain-swapping experiments:

    • Exchanging specific regions between spike proteins with differing properties

    • Allows identification of precise functional elements

  • In vitro and in vivo validation:

    • Testing in cell culture to assess replication kinetics

    • Animal challenge studies to evaluate pathogenicity

    • Measurement of clinical signs, viral shedding (reaching 8.3-8.4 log₁₀ genome copies/mL in virulent strains), seroconversion rates, and mortality

These approaches have demonstrated that spike proteins alone can determine virulence phenotypes independent of other viral components, making them crucial targets for vaccine development and attenuated strain design .

What bioinformatics approaches yield insights into spike protein evolution and variation?

Key bioinformatics approaches include:

  • Sequence analysis:

    • Multiple sequence alignment identifies conserved and variable regions

    • Phylogenetic analysis established that PDCoV likely evolved from avian deltacoronavirus ancestors

  • Structural prediction:

    • Prediction of physical/chemical properties, hydrophilicity, and functional elements

    • Homology modeling for novel variants

  • Functional element prediction:

    • Identification of epitopes: TGEV (53), PEDV (51), SADS-CoV (43), PDCoV (52)

    • Mapping post-translational modifications

  • Recombination analysis:

    • Detection of potential genetic exchanges between viruses

    • Similar to SARS-CoV-2, where six of nine identified recombinations were in the spike gene

  • Comparative genomics:

    • Identification of insertions/deletions, such as the 15 bp insertion and 6 bp deletion in Korean PEDV isolates

    • Analysis of selective pressures across species

These computational approaches complement experimental studies and guide targeted investigations of spike protein function.

How do receptor binding mechanisms of porcine coronaviruses compare with SARS-CoV-2?

Important similarities and differences exist between porcine coronaviruses and SARS-CoV-2:

  • Receptor utilization:

    • PDCoV uses aminopeptidase N (APN) from multiple species

    • SARS-CoV-2 uses ACE2 as its primary receptor

  • Cross-species potential:

    • PDCoV shows broad receptor usage across species, including documented human infections

    • SARS-CoV-2 RBD is described as a "hotspot for adaptive mutations that enhance binding efficiency to its human host"

  • Structural adaptations:

    • Alphacoronaviruses like PEDV have a unique N-terminal domain 0 (D0) not found in betacoronaviruses like SARS-CoV-2

    • SARS-CoV-2 contains a distinctive furin cleavage site that may enhance transmissibility

  • Evolutionary patterns:

    • Both demonstrate recombination events in spike genes

    • PDCoV likely evolved from avian deltacoronavirus ancestors

    • SARS-CoV-2 likely evolved from bat coronaviruses, possibly with intermediate hosts

Understanding these comparative mechanisms helps identify common principles in coronavirus host recognition and informs surveillance for emerging threats.

How can glycosylation analysis of porcine coronavirus spikes inform human coronavirus vaccine design?

Glycosylation plays crucial roles in spike protein function across coronavirus genera:

  • Glycan shield effects:

    • N-linked glycans can shield viral epitopes from antibody recognition

    • Similar strategies are employed by both porcine coronaviruses and SARS-CoV-2

  • Conformational regulation:

    • In PEDV, specific N-glycans modulate the D0 domain conformation

    • Similar effects likely influence SARS-CoV-2 spike dynamics

  • Glycosylation mapping techniques:

    • Integrated mass spectrometry and cryo-EM approaches developed for porcine coronaviruses

    • Can be applied to human coronavirus vaccine antigen characterization

  • Vaccine antigen considerations:

    • Proper glycosylation patterns are essential for recombinant spike-based vaccines

    • Expression systems must be selected carefully to ensure appropriate post-translational modifications

  • Strain variations:

    • Glycosylation site differences between virus strains may contribute to antigenic differences

    • Comparative analysis across strains can identify conserved sites for broadly protective vaccine design

These insights from porcine coronavirus research can guide optimization of glycosylation in human coronavirus vaccine antigens, potentially improving immunogenicity and protective efficacy.

Product Science Overview

Introduction

Mouse anti-porcine coronavirus spike monoclonal antibodies are specialized antibodies produced by mice that target the spike protein of porcine coronaviruses. These antibodies are crucial for research and diagnostic purposes, particularly in the study of porcine epidemic diarrhea virus (PEDV) and porcine deltacoronavirus (PDCoV), which are significant pathogens in the swine industry.

Porcine Coronaviruses

Porcine coronaviruses belong to the Coronaviridae family and are responsible for causing severe enteric diseases in pigs. The two primary porcine coronaviruses of concern are PEDV and PDCoV.

  • Porcine Epidemic Diarrhea Virus (PEDV): PEDV is an RNA virus that causes porcine epidemic diarrhea (PED), characterized by severe diarrhea, vomiting, and dehydration in pigs. The disease poses a high mortality risk, especially for suckling piglets . PEDV was first identified in Europe and Asia in the early 1970s and has since spread globally, causing substantial economic losses in the pig-breeding industry .
  • Porcine Deltacoronavirus (PDCoV): PDCoV is another enteric coronavirus that emerged more recently. It has the potential for cross-species transmission, raising concerns about its impact on both animal and human health .
Spike Protein and Its Importance

The spike (S) protein of coronaviruses is a critical component of the virus’s structure. It facilitates the virus’s entry into host cells by binding to specific receptors on the cell surface. The S protein is also the primary target for neutralizing antibodies, making it a key focus for vaccine and therapeutic development.

Development of Monoclonal Antibodies

Monoclonal antibodies (mAbs) are antibodies produced by identical immune cells that are clones of a unique parent cell. They are highly specific to a particular antigen, in this case, the spike protein of porcine coronaviruses.

  • Production: To produce mouse anti-porcine coronavirus spike monoclonal antibodies, researchers typically immunize mice with the spike protein or its subunits. The immune response generates B cells that produce antibodies against the spike protein. These B cells are then fused with myeloma cells to create hybridomas, which can be cultured to produce large quantities of monoclonal antibodies .
  • Characterization: The monoclonal antibodies are characterized using various assays, such as enzyme-linked immunosorbent assay (ELISA), indirect immunofluorescence assay (IFA), and flow cytometry assay (FCA). These assays help determine the antibodies’ specificity, affinity, and effectiveness in detecting the spike protein .
Applications

Mouse anti-porcine coronavirus spike monoclonal antibodies have several important applications:

  • Diagnostic Tools: These antibodies are used in diagnostic assays to detect the presence of porcine coronaviruses in clinical samples. They can identify viral infections early, allowing for timely intervention and control measures .
  • Research: Monoclonal antibodies are valuable tools in research to study the virus-host interactions, understand the mechanisms of viral entry, and evaluate the efficacy of vaccines and antiviral therapies .
  • Therapeutics: In some cases, monoclonal antibodies can be developed as therapeutic agents to neutralize the virus and prevent infection. They can also be used in passive immunization strategies to protect vulnerable populations, such as suckling piglets .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.